Eisai
Harald Hampel, MD, PhD, MSc is an accomplished neurologist with extensive expertise in medical affairs, particularly in neurology and Alzheimer's disease. Currently serving as Chief Medical Officer and Senior Vice President at Eisai US since May 2019, Harald leads global medical affairs strategy and oversees critical projects related to Alzheimer's and dementia. With prior positions including full professorships at Université Paris-Sorbonne and Goethe University, as well as significant leadership roles at Trinity College Dublin and Ludwig-Maximilians Universität München, Harald has cultivated a distinguished career in clinical research and academia. Educational credentials include a Doctor of Medicine and concurrent PhD in Neurobiology from the University of Munich, along with additional degrees in Business Administration and Medicine.
This person is not in any teams
This person is not in any offices
Eisai
12 followers
Eisai Co., Ltd. is engaged in the research and development, manufacture, sale and import and export of pharmaceuticals. The Company's business segments include pharmaceutical segment and other segment. The pharmaceutical segment is engaged in the research, develop, manufacture and sale of pharmaceuticals for medical use, generic drugs, general medicines, among others. The other segment consists of pharmaceutical raw materials, logistics services and business services businesses.